U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. For Consumers
  3. Women's Health
  4. OWH Education and Training
  5. Women's Health Events
  6. OWH Continuing Education (CE)
  1. Women's Health Events

OWH Continuing Education (CE)

From the FDA Office of Women's Health

Image
​ ​Multi ethnic group of medical students

On this page: About CE | Current CE event recordings

About CE

In addition to offering live events with continuing education, the FDA Office of Women’s Health (OWH) also offers recordings of previous events for continuing education credit. Various types of continuing education (CE) that may be available include:

  • CME – continuing medical education
  • CNE – continuing nursing education
  • CPE – continuing pharmacy education

Please see each event page for instructions to claim CE credit after viewing the recording.

Please also see our previous events page for a list of additional event recordings available to view on demand. Don’t miss upcoming OWH events!

Current CE event recordings

  • November 15, 2023: Hyperemesis Gravidarum: New Research and Insights 

OWH hosted a webinar featuring Dr. Marlena Fejzo, Assistant Professor of Clinical Population and Public Health Sciences, Univ. of Southern California, Los Angeles. This webinar reviewed the latest research on maternal, fetal, and child adverse outcomes for the most severe form of nausea and vomiting caused by pregnancy, hyperemesis gravidarum. Etiology, treatment, and pre-clinical evidence for novel mechanisms of prevention and therapy were discussed. 

  • November 8, 2023: Bringing Clinical Research to Patients

OWH, in collaboration with the Center for Drug Evaluation and Research (CDER) Office of Medical Policy (OMP), hosted a free public webinar to discuss the new strategies currently available for bringing clinical research to all patients, including women. 

  • May 17, 2023: PCOS Revisited: Diagnosis, Management, and Future Needs 

Dr. Kathleen Hoeger reviewed the pathophysiology, diagnosis, comorbidities, and findings from recent research on Polycystic Ovary Syndrome in this OWH-hosted webinar.

  • October 27, 2022: Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation 

OWH, in collaboration with CDER’s Division of Pediatrics and Maternal Health, hosted a webinar to discuss an overview of the studies enrolling pregnant and lactating women. The presentation discussed the work FDA is doing to advance research in pregnant and lactating women, and provided information on how providers can become involved in advancing research in pregnant and lactating women. 

  • May 11, 2022: Pregnancy and Lactation Medication Information for the Healthcare Provider 

OWH hosted a webinar in collaboration with CDER’s Division of Pediatrics and Maternal Health to discuss FDA’s current pregnancy and lactation labeling system [also known as the Pregnancy and Lactation Labeling Rule (PLLR)], which replaced a previous approach that used letter categories. This webinar will help learners examine how prescription drug labeling can be used to inform prescribing for pregnant and lactating women. 

Back to Top